Also trades as: ODTC (OTC) · $vol 0M
ODT NASDAQ
Odonate Therapeutics, Inc.
1W: +2.8%
1M: -24.3%
3M: -62.9%
1Y: -94.4%
3Y: -93.2%
$1.12
Last traded 2022-01-14 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$127M
-10.9% ▼
Net Income
-$126M
-13.0% ▼
EPS (Diluted)
$-3.85
+4.9% ▲
EBITDA
-$127M
-13.9% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $3M | $28M | $80M | $104M | $117M |
| SG&A Expenses | $463K | $5M | $11M | $11M | $10M |
| Operating Expenses | $3M | $33M | $91M | $115M | $127M |
| Operating Income | -$3M | -$33M | -$91M | -$115M | -$127M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$3M | -$33M | -$89M | -$112M | -$126M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$3M | -$33M | -$89M | -$112M | -$126M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.11 | $-1.28 | $-3.64 | $-4.05 | $-3.85 |
| EBITDA | -$3M | -$33M | -$89M | -$111M | -$127M |
| Shares Outstanding | 27M | 26M | 24M | 28M | 33M |